Primary Site >> Colorectal Cancer
Gene >> SETBP1
|
|
|
|
|
|---|---|---|---|---|
|
Ref: Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor. PMID: 1645269 Ref: Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents. PMID: 1924393 |
Ref: Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells. PMID: 1487309 |
Ref: The immunomodulatory effect of levamisole is influenced by postoperative changes and type of lymphocyte stimulant. PMID: 7553689 Ref: Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma. PMID: 7641220 Ref: Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEA. PMID: 8696008 |
Ref: Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials. PMID: 8993796 |
Ref: Analysis of Potential Alterations Affecting SETBP1 as a Novel Contributing Mechanism to Inhibit PP2A in Colorectal Cancer Patients. PMID: 29796729 |